Hilton Capital Management’s Chemours CC Stock Holding History

Hilton Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-124	Closed	-$2K	–	145
2019 Q3	$2K	Hold	124	–	–	﹤0.01%	308
2019 Q2	$3K	Hold	124	–	–	﹤0.01%	333
2019 Q1	$5K	Hold	124	–	–	﹤0.01%	323
2018 Q4	$3K	Hold	124	–	–	﹤0.01%	307
2018 Q3	$5K	Hold	124	–	–	﹤0.01%	297
2018 Q2	$6K	Buy	+124	New	+$6.17K	﹤0.01%	320

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hilton Capital Management's CC Position: Q4 2019 in Review

Hilton Capital Management sold out of Chemours (CC) in Q4 2019, closing a stake of 124 shares — an estimated $2K sold.

Hilton Capital Management first reported a position in CC in Q2 2018 and held it in 6 quarters. The position peaked at $6K in Q2 2018. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

Hilton Capital Management reported no remaining Chemours position as of Q4 2019 after selling out during the quarter.
Hilton Capital Management sold 124 Chemours shares in Q4 2019, an estimated $2K.
Hilton Capital Management first reported a position in Chemours in Q2 2018 and held it in 6 quarters.
Hilton Capital Management's Chemours position peaked at $6K in Q2 2018.
439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on Hilton Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.